Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kline

Showing results (161-170 of 189) with videos related to

Pageof 19
Sort By:
Journal for Immunotherapy of Cancer|December 28, 2020
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphomaSattva S Neelapu, Sherry Adkins, Stephen M Ansell, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|November 12, 2010
Characterization of conformational adsorbate changes on a tissue-derived substrate using Fourier transform infrared spectroscopyMarcus A Kramer, Benjamin Andrews, Daniel L Hugar, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 12, 2023
Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHLAlexandra E Rojek, Justin P Kline, Nicholas Feinberg, et al.
Plos One|February 23, 2017
Bacterial expression, correct membrane targeting and functional folding of the HIV-1 membrane protein Vpu using a periplasmic signal peptideArpan Deb, William A Johnson, Alexander P Kline, et al.
Haematologica|October 5, 2019
Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patientsIva Truxova, Lenka Kasikova, Cyril Salek, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Low-Strength Type I Interferon Signaling Promotes CAR T-Cell Treatment EfficacyErting Tang, Yifei Hu, Guoshuai Cao, et al.
Journal for Immunotherapy of Cancer|June 26, 2023
TIGIT is a key inhibitory checkpoint receptor in lymphomaJames Godfrey, Xiufen Chen, Nicole Sunseri, et al.
Journal of Geriatric Oncology|November 9, 2020
Recommendations and outcomes from a geriatric assessment guided multidisciplinary clinic prior to autologous stem cell transplant in older patientsBenjamin A Derman, Keriann Kordas, Emily Molloy, et al.
Cancer Immunology Research|May 11, 2026
Low-Strength Type I Interferon Signaling Promotes CAR T Cell Treatment EfficacyErting Tang, Yifei Hu, Guoshuai Cao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2006
Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disordersAnne J Novak, Deanna M Grote, Steven C Ziesmer, et al.
Pageof 19

Showing results (161-170 of 189) with videos related to

Sort By:
Pageof 19
Journal for Immunotherapy of Cancer|December 28, 2020
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphomaSattva S Neelapu, Sherry Adkins, Stephen M Ansell, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|November 12, 2010
Characterization of conformational adsorbate changes on a tissue-derived substrate using Fourier transform infrared spectroscopyMarcus A Kramer, Benjamin Andrews, Daniel L Hugar, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 12, 2023
Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHLAlexandra E Rojek, Justin P Kline, Nicholas Feinberg, et al.
Plos One|February 23, 2017
Bacterial expression, correct membrane targeting and functional folding of the HIV-1 membrane protein Vpu using a periplasmic signal peptideArpan Deb, William A Johnson, Alexander P Kline, et al.
Haematologica|October 5, 2019
Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patientsIva Truxova, Lenka Kasikova, Cyril Salek, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Low-Strength Type I Interferon Signaling Promotes CAR T-Cell Treatment EfficacyErting Tang, Yifei Hu, Guoshuai Cao, et al.
Journal for Immunotherapy of Cancer|June 26, 2023
TIGIT is a key inhibitory checkpoint receptor in lymphomaJames Godfrey, Xiufen Chen, Nicole Sunseri, et al.
Journal of Geriatric Oncology|November 9, 2020
Recommendations and outcomes from a geriatric assessment guided multidisciplinary clinic prior to autologous stem cell transplant in older patientsBenjamin A Derman, Keriann Kordas, Emily Molloy, et al.
Cancer Immunology Research|May 11, 2026
Low-Strength Type I Interferon Signaling Promotes CAR T Cell Treatment EfficacyErting Tang, Yifei Hu, Guoshuai Cao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2006
Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disordersAnne J Novak, Deanna M Grote, Steven C Ziesmer, et al.
Pageof 19